ArticlePloS one2011

EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.

Romana Ruiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.